Saltar al contenido

Texas Compounding Pharmacy Recalls 261 Lots of Injections, Most of Them Compounded Semaglutide and Tirzepatide, Over Sterility Concerns

22 de noviembre de 2026 · 3 min

Notas del episodio

A Texas compounding pharmacy is recalling 261 lots of compounded sterile injections nationwide, and most of them are compounded semaglutide and tirzepatide. Greenwich Rx, a 503A compounding pharmacy in Tomball, Texas, announced the voluntary recall on November 20, 2026, citing a potential lack of sterility assurance after an FDA inspection and its own review; the FDA posted the announcement the same day. The products were dispensed nationwide between August 10 and September 21, 2026, including some compounded for another pharmacy, Clove Rx. On the company's published lot list, 203 of the 261 entries are compounded semaglutide or tirzepatide combination products (mixed with vitamin B12, glycine, methylcobalamin or L-carnitine); the rest are other compounded injections. Greenwich Rx says it has found no evidence of contamination and has received no adverse event reports tied to the recall. No brand-name medicine appears on the list. We also cover what the FDA says about compounded GLP-1 drugs, which are not FDA approved and are not reviewed for safety, effectiveness or quality before they are marketed.

Sources

  • U.S. FDA (Nov 20, 2026), company announcement: Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Sterile Products Due to Lack of Sterility Assurance: fda.gov
  • Greenwich Rx (Nov 20, 2026), recall announcement and full list of affected products and lots: greenwichrx.org
  • U.S. FDA, FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss: fda.gov
  • BariatricPal News (Nov 2026), independent tally of the recall list: bariatricpal.com

Cover: original code-generated illustration (no photo).

This episode is for information only and is not medical advice. Always talk to your doctor before starting, stopping, or changing any medication.

Visit glp1newspaper.com for today's stories and free email alerts.

Todos los episodios de GLP-1 Newspaper: Daily Ozempic, Zepbound & Weight-Loss Drug News

Ajustes

Visualización

Idioma

Determina qué emisoras ves primero en la página de inicio.

Historial

Las emisoras y episodios escuchados recientemente y tus últimas búsquedas solo se guardan en este navegador.

Avisos

Un breve aviso cuando un pódcast que sigues tiene un episodio nuevo. Puedes desactivar pódcast concretos con la campana de su página.

Cuenta

Guarda tus favoritos: en la app y en la web.

Atajos de teclado

/
Abrir búsqueda
Espacio
Reproducir o pausar
← →
En el reproductor: 15 s atrás, 30 s adelante (episodios) · en una fila: siguiente tarjeta
↑ ↓
En una fila: destino dentro de la tarjeta
Inicio / Fin
En una fila: primera o última tarjeta
Esc
Cerrar ventana o menú
?
Este resumen
Reproduciendo ahora

Ir a la emisora

A continuación

    Añade episodios con «A continuación»: sonarán después del episodio actual.